None
Quote | Propanc Biopharma Inc (OTCMKTS:PPCB)
Last: | $0.001 |
---|---|
Change Percent: | 0.0% |
Open: | $0.0008 |
Close: | $0.001 |
High: | $0.001 |
Low: | $0.00075 |
Volume: | 35,421,162 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Propanc Biopharma Inc (OTCMKTS:PPCB)
British Journal of Cancer Concludes Tumor cell-intrinsic PD-L1 function promotes EMT Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recu...
Certificate of Grant Received for “Cancer Treatment” Patent from IP Corporation of Malaysia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patient...
Message Board Posts | Propanc Biopharma Inc (OTCMKTS:PPCB)
Subject | By | Source | When |
---|---|---|---|
Yes and $.0004s should return to the ASK | Da Stock Alpaca | investorshub | 05/01/2023 8:08:34 PM |
Holy moly 440Million on the Bid. Some folks | BeachKing | investorshub | 05/01/2023 8:02:18 PM |
Trades for the day: https://ih.advfn.com/stock-market/USOTC/propanc-biopharma-p | linkvest | investorshub | 05/01/2023 8:00:43 PM |
$.0004s almost back up! | Da Stock Alpaca | investorshub | 05/01/2023 7:51:30 PM |
Im showing < 8 million $.0003s on the | Da Stock Alpaca | investorshub | 05/01/2023 7:30:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Propanc Biopharma Inc Company Name:
PPCB Stock Symbol:
OTCMKTS Market:
Propanc Biopharma Inc Website:
British Journal of Cancer Concludes Tumor cell-intrinsic PD-L1 function promotes EMT Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recu...
Certificate of Grant Received for “Cancer Treatment” Patent from IP Corporation of Malaysia Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patient...
Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that a certificate of grant for the Company’s &...